Bulgarian pharmaceutical manufacturers resumed production in July after the country closed its borders with Turkey and Greece.
Bulgaria’s pharmaceutical manufacturing resumed on July 20, 2016, just days after the European Union imposed a ban on Bulgarian products due to the deadly outbreak of a coronavirus in the country.
The country was one of the first to officially lift its ban on all imports in September, after EU leaders decided to impose a three-month quarantine on Bulgarian citizens returning from the country due to a coronovirus outbreak.
Bulgarian President Omer Celik said at the time that the closure of Bulgarian pharmaceuticals could affect the country’s economy.
The closure of the countrys pharmaceutical industry has been the biggest obstacle to Bulgaria’s recovery from the coronaviral pandemic, which has claimed more than 8,000 lives and affected more than 7,000, according to the European Commission.